Boston, Massachusetts, April 16, 2026
Vaderis Therapeutics’ Senior Medical Director & Co-Founder, Dr. Damien Picard, recently participated in a panel discussion about hereditary hemorrhagic telangiectasia (HHT) as part of Mass General Brigham’s Life Changing Research Town Hall. The panel discussion provided information about HHT, the clinical development work for Engasertib, as well as perspective from Cure HHT, a patient advocacy group.
The town hall can be viewed here:
https://mgb.mediasite.com/Mediasite/Play/4af29f9a7dd74742bfb80896d53408871d
(Town hall link posted with permission from Mass General Brigham)